ArticleChemMedChem2026

Development of a Lysine-Reactive Targeted Covalent Inhibitor for the P300/CBP-Associated Factor Bromodomain Through Structure-Based Design.

Richard R Ede et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.